| 
            
              US5916588A
              (en)
            
            *
            
           | 
          1984-04-12 | 
          1999-06-29 | 
          The Liposome Company, Inc. | 
          Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use 
        | 
        
        
          | 
            
              US6090406A
              (en)
            
            *
            
           | 
          1984-04-12 | 
          2000-07-18 | 
          The Liposome Company, Inc. | 
          Potentiation of immune responses with liposomal adjuvants 
        | 
        
        
          | 
            
              US4761287A
              (en)
            
            *
            
           | 
          1984-05-03 | 
          1988-08-02 | 
          Technology Unlimited, Inc. | 
          Diabetes control by serotonin 
        | 
        
        
          | 
            
              US4767615A
              (en)
            
            *
            
           | 
          1984-05-03 | 
          1988-08-30 | 
          Technology Unlimited, Inc. | 
          Dental therapy by vesicle delivery 
        | 
        
        
          | 
            
              US4863896A
              (en)
            
            *
            
           | 
          1984-05-03 | 
          1989-09-05 | 
          Technology Unlimited, Inc. | 
          Diabetic control by combined insulin forms 
        | 
        
        
          | 
            
              US4740375A
              (en)
            
            *
            
           | 
          1985-02-25 | 
          1988-04-26 | 
          Technology Unlimited, Inc. | 
          Gelcores 
        | 
        
        
          | 
            
              US4828982A
              (en)
            
            *
            
           | 
          1985-05-28 | 
          1989-05-09 | 
          Becton, Dickinson & Company | 
          Vesticles and use thereof in an enzyme assay 
        | 
        
        
          | 
            
              NZ217821A
              (en)
            
            *
            
           | 
          1985-10-10 | 
          1989-07-27 | 
          Biotech Australia Pty Ltd | 
          Oral delivery system; complex of active agent and vitamin b12 or analogue thereof 
      | 
        
        
          | 
            
              US5023086A
              (en)
            
            *
            
           | 
          1987-03-13 | 
          1991-06-11 | 
          Micro-Pak, Inc. | 
          Encapsulated ionophore growth factors 
        | 
        
        
          | 
            
              US5000960A
              (en)
            
            *
            
           | 
          1987-03-13 | 
          1991-03-19 | 
          Micro-Pak, Inc. | 
          Protein coupling to lipid vesicles 
        | 
        
        
          | 
            
              PH26549A
              (en)
            
            *
            
           | 
          1987-04-03 | 
          1992-08-19 | 
          Meito Sangyo Kk | 
          Mannobiose derivatives 
      | 
        
        
          | 
            
              US5807832A
              (en)
            
            *
            
           | 
          1987-06-09 | 
          1998-09-15 | 
          Biotech Australia Pty Limited | 
          Oral delivery of biologically active substances bound to vitamin B12 
        | 
        
        
          | 
            
              DE3853079T3
              (de)
            
            *
            
           | 
          1987-12-04 | 
          2000-11-09 | 
          The Liposome Co.,Inc. | 
          Liposome hoher stabilität und verfahren zur herstellung und verwendung. 
        | 
        
        
          | 
            
              DE3886775T2
              (de)
            
            
            
           | 
          1988-08-22 | 
          1994-04-14 | 
          Technology Unlimited Inc | 
          Zahnbehandlung durch freisetzung von vesikeln. 
        | 
        
        
          | 
            
              US4942036A
              (en)
            
            *
            
           | 
          1988-08-25 | 
          1990-07-17 | 
          Blair Geho W | 
          Therapy by vesicle delivery to the hydroxyapatite of bone 
        | 
        
        
          | 
            
              US5026558A
              (en)
            
            *
            
           | 
          1989-01-31 | 
          1991-06-25 | 
          University Of Southern California | 
          Targeting drugs to hepatocytes in the liver 
        | 
        
        
          | 
            
              US5104661A
              (en)
            
            *
            
           | 
          1989-08-14 | 
          1992-04-14 | 
          Technology Unlimited, Inc. | 
          Reverse loading of liposomes 
        | 
        
        
          | 
            
              US5230882A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1993-07-27 | 
          Unger Evan C | 
          Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 
        | 
        
        
          | 
            
              US5469854A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1995-11-28 | 
          Imarx Pharmaceutical Corp. | 
          Methods of preparing gas-filled liposomes 
        | 
        
        
          | 
            
              US5773024A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1998-06-30 | 
          Imarx Pharmaceutical Corp. | 
          Container with multi-phase composition for use in diagnostic and therapeutic applications 
        | 
        
        
          | 
            
              US5088499A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1992-02-18 | 
          Unger Evan C | 
          Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 
        | 
        
        
          | 
            
              US5733572A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1998-03-31 | 
          Imarx Pharmaceutical Corp. | 
          Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles 
        | 
        
        
          | 
            
              US6088613A
              (en)
            
            
            
           | 
          1989-12-22 | 
          2000-07-11 | 
          Imarx Pharmaceutical Corp. | 
          Method of magnetic resonance focused surgical and therapeutic ultrasound 
        | 
        
        
          | 
            
              US5656211A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1997-08-12 | 
          Imarx Pharmaceutical Corp. | 
          Apparatus and method for making gas-filled vesicles of optimal size 
        | 
        
        
          | 
            
              US5776429A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1998-07-07 | 
          Imarx Pharmaceutical Corp. | 
          Method of preparing gas-filled microspheres using a lyophilized lipids 
        | 
        
        
          | 
            
              US5352435A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1994-10-04 | 
          Unger Evan C | 
          Ionophore containing liposomes for ultrasound imaging 
        | 
        
        
          | 
            
              US5705187A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1998-01-06 | 
          Imarx Pharmaceutical Corp. | 
          Compositions of lipids and stabilizing materials 
        | 
        
        
          | 
            
              US6551576B1
              (en)
            
            
            
           | 
          1989-12-22 | 
          2003-04-22 | 
          Bristol-Myers Squibb Medical Imaging, Inc. | 
          Container with multi-phase composition for use in diagnostic and therapeutic applications 
        | 
        
        
          | 
            
              US5123414A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1992-06-23 | 
          Unger Evan C | 
          Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 
        | 
        
        
          | 
            
              US5580575A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1996-12-03 | 
          Imarx Pharmaceutical Corp. | 
          Therapeutic drug delivery systems 
        | 
        
        
          | 
            
              US5585112A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1996-12-17 | 
          Imarx Pharmaceutical Corp. | 
          Method of preparing gas and gaseous precursor-filled microspheres 
        | 
        
        
          | 
            
              US5542935A
              (en)
            
            
            
           | 
          1989-12-22 | 
          1996-08-06 | 
          Imarx Pharmaceutical Corp. | 
          Therapeutic delivery systems related applications 
        | 
        
        
          | 
            
              US6146657A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          2000-11-14 | 
          Imarx Pharmaceutical Corp. | 
          Gas-filled lipid spheres for use in diagnostic and therapeutic applications 
        | 
        
        
          | 
            
              US5922304A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1999-07-13 | 
          Imarx Pharmaceutical Corp. | 
          Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents 
        | 
        
        
          | 
            
              US5305757A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1994-04-26 | 
          Unger Evan C | 
          Gas filled liposomes and their use as ultrasonic contrast agents 
        | 
        
        
          | 
            
              US20020150539A1
              (en)
            
            
            
           | 
          1989-12-22 | 
          2002-10-17 | 
          Unger Evan C. | 
          Ultrasound imaging and treatment 
        | 
        
        
          | 
            
              US5334381A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1994-08-02 | 
          Unger Evan C | 
          Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same 
        | 
        
        
          | 
            
              US6001335A
              (en)
            
            *
            
           | 
          1989-12-22 | 
          1999-12-14 | 
          Imarx Pharmaceutical Corp. | 
          Contrasting agents for ultrasonic imaging and methods for preparing the same 
        | 
        
        
          | 
            
              US5213810A
              (en)
            
            *
            
           | 
          1990-03-30 | 
          1993-05-25 | 
          American Cyanamid Company | 
          Stable compositions for parenteral administration and method of making same 
        | 
        
        
          | 
            
              US5190822A
              (en)
            
            *
            
           | 
          1990-04-20 | 
          1993-03-02 | 
          Fuji Photo Film Co., Ltd. | 
          Surface-modifiable liposome and process for producing surface-modified liposome 
        | 
        
        
          | 
            
              AU707085B2
              (en)
            
            *
            
           | 
          1991-04-02 | 
          1999-07-01 | 
          Access Pharmaceuticals Australia Pty Limited | 
          Oral delivery systems for microparticles 
        | 
        
        
          | 
            
              CA2084194C
              (en)
            
            *
            
           | 
          1991-04-02 | 
          2003-05-20 | 
          Gregory John Russell-Jones | 
          Oral delivery systems for microparticles 
        | 
        
        
          | 
            
              US5874062A
              (en)
            
            *
            
           | 
          1991-04-05 | 
          1999-02-23 | 
          Imarx Pharmaceutical Corp. | 
          Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents 
        | 
        
        
          | 
            
              US5205290A
              (en)
            
            
            
           | 
          1991-04-05 | 
          1993-04-27 | 
          Unger Evan C | 
          Low density microspheres and their use as contrast agents for computed tomography 
        | 
        
        
          | 
            
              AU653026B2
              (en)
            
            *
            
           | 
          1991-06-07 | 
          1994-09-15 | 
          Teikoku Seiyaku Kabushiki Kaisha | 
          Physiologically active polypeptide-containing pharmaceutical composition 
        | 
        
        
          | 
            
              US7083572B2
              (en)
            
            
            
           | 
          1993-11-30 | 
          2006-08-01 | 
          Bristol-Myers Squibb Medical Imaging, Inc. | 
          Therapeutic delivery systems 
        | 
        
        
          | 
            
              US5534499A
              (en)
            
            *
            
           | 
          1994-05-19 | 
          1996-07-09 | 
          The University Of British Columbia | 
          Lipophilic drug derivatives for use in liposomes 
        | 
        
        
          | 
            
              US5736121A
              (en)
            
            *
            
           | 
          1994-05-23 | 
          1998-04-07 | 
          Imarx Pharmaceutical Corp. | 
          Stabilized homogenous suspensions as computed tomography contrast agents 
        | 
        
        
          | 
            
              GB9420390D0
              (en)
            
            *
            
           | 
          1994-10-10 | 
          1994-11-23 | 
          Nycomed Salutar Inc | 
          Liposomal agents 
      | 
        
        
          | 
            
              US6743779B1
              (en)
            
            
            
           | 
          1994-11-29 | 
          2004-06-01 | 
          Imarx Pharmaceutical Corp. | 
          Methods for delivering compounds into a cell 
        | 
        
        
          | 
            
              US5830430A
              (en)
            
            *
            
           | 
          1995-02-21 | 
          1998-11-03 | 
          Imarx Pharmaceutical Corp. | 
          Cationic lipids and the use thereof 
        | 
        
        
          | 
            
              US5997898A
              (en)
            
            *
            
           | 
          1995-06-06 | 
          1999-12-07 | 
          Imarx Pharmaceutical Corp. | 
          Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery 
        | 
        
        
          | 
            
              US6139819A
              (en)
            
            *
            
           | 
          1995-06-07 | 
          2000-10-31 | 
          Imarx Pharmaceutical Corp. | 
          Targeted contrast agents for diagnostic and therapeutic use 
        | 
        
        
          | 
            
              US6033645A
              (en)
            
            *
            
           | 
          1996-06-19 | 
          2000-03-07 | 
          Unger; Evan C. | 
          Methods for diagnostic imaging by regulating the administration rate of a contrast agent 
        | 
        
        
          | 
            
              US6231834B1
              (en)
            
            
            
           | 
          1995-06-07 | 
          2001-05-15 | 
          Imarx Pharmaceutical Corp. | 
          Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same 
        | 
        
        
          | 
            
              US6521211B1
              (en)
            
            
            
           | 
          1995-06-07 | 
          2003-02-18 | 
          Bristol-Myers Squibb Medical Imaging, Inc. | 
          Methods of imaging and treatment with targeted compositions 
        | 
        
        
          | 
            
              EP0935415B1
              (en)
            
            
            
           | 
          1996-05-01 | 
          2006-11-22 | 
          Imarx Pharmaceutical Corp. | 
          In vitro methods for delivering nucleic acids into a cell 
        | 
        
        
          | 
            
              GB9612264D0
              (en)
            
            *
            
           | 
          1996-06-12 | 
          1996-08-14 | 
          Samsoondar James | 
          Quality control material for monitoring calibration of instruments designed to measure serum and plasma specimen integrity 
      | 
        
        
          | 
            
              US7157282B2
              (en)
            
            *
            
           | 
          1996-06-12 | 
          2007-01-02 | 
          Spectromedical Inc. | 
          Quality control material for reagentless measurement of analytes 
        | 
        
        
          | 
            
              US6828152B2
              (en)
            
            *
            
           | 
          1996-06-12 | 
          2004-12-07 | 
          Spectromedical Inc. | 
          Quality control material for reagentless measurement of analytes 
        | 
        
        
          | 
            
              US6414139B1
              (en)
            
            
            
           | 
          1996-09-03 | 
          2002-07-02 | 
          Imarx Therapeutics, Inc. | 
          Silicon amphiphilic compounds and the use thereof 
        | 
        
        
          | 
            
              JP4139440B2
              (ja)
            
            *
            
           | 
          1996-09-11 | 
          2008-08-27 | 
          イマアーレクス・フアーマシユーチカル・コーポレーシヨン | 
          造影剤及び血管拡張薬を用いる画像診断のための改良された方法 
        | 
        
        
          | 
            
              US5846517A
              (en)
            
            *
            
           | 
          1996-09-11 | 
          1998-12-08 | 
          Imarx Pharmaceutical Corp. | 
          Methods for diagnostic imaging using a renal contrast agent and a vasodilator 
        | 
        
        
          | 
            
              US6537246B1
              (en)
            
            
            
           | 
          1997-06-18 | 
          2003-03-25 | 
          Imarx Therapeutics, Inc. | 
          Oxygen delivery agents and uses for the same 
        | 
        
        
          | 
            
              US6143276A
              (en)
            
            *
            
           | 
          1997-03-21 | 
          2000-11-07 | 
          Imarx Pharmaceutical Corp. | 
          Methods for delivering bioactive agents to regions of elevated temperatures 
        | 
        
        
          | 
            
              US6090800A
              (en)
            
            *
            
           | 
          1997-05-06 | 
          2000-07-18 | 
          Imarx Pharmaceutical Corp. | 
          Lipid soluble steroid prodrugs 
        | 
        
        
          | 
            
              US6120751A
              (en)
            
            
            
           | 
          1997-03-21 | 
          2000-09-19 | 
          Imarx Pharmaceutical Corp. | 
          Charged lipids and uses for the same 
        | 
        
        
          | 
            
              US7452551B1
              (en)
            
            
            
           | 
          2000-10-30 | 
          2008-11-18 | 
          Imarx Therapeutics, Inc. | 
          Targeted compositions for diagnostic and therapeutic use 
        | 
        
        
          | 
            
              US6416740B1
              (en)
            
            
            
           | 
          1997-05-13 | 
          2002-07-09 | 
          Bristol-Myers Squibb Medical Imaging, Inc. | 
          Acoustically active drug delivery systems 
        | 
        
        
          | 
            
              CA2294900A1
              (en)
            
            *
            
           | 
          1997-07-02 | 
          1999-01-14 | 
          Sdg, Inc. | 
          Targeted liposomal constructs for diagnostic and therapeutic uses 
      | 
        
        
          | 
            
              US6548047B1
              (en)
            
            
            
           | 
          1997-09-15 | 
          2003-04-15 | 
          Bristol-Myers Squibb Medical Imaging, Inc. | 
          Thermal preactivation of gaseous precursor filled compositions 
        | 
        
        
          | 
            
              GB9721901D0
              (en)
            
            
            
           | 
          1997-10-16 | 
          1997-12-17 | 
          Univ Manchester | 
          Particles 
      | 
        
        
          | 
            
              EP1903114A3
              (en)
            
            
            
           | 
          1997-12-01 | 
          2008-07-23 | 
          Neose Technologies, Inc. | 
          Enzymatic synthesis of gangliosides 
        | 
        
        
          | 
            
              US6123923A
              (en)
            
            *
            
           | 
          1997-12-18 | 
          2000-09-26 | 
          Imarx Pharmaceutical Corp. | 
          Optoacoustic contrast agents and methods for their use 
        | 
        
        
          | 
            
              US6320017B1
              (en)
            
            *
            
           | 
          1997-12-23 | 
          2001-11-20 | 
          Inex Pharmaceuticals Corp. | 
          Polyamide oligomers 
        | 
        
        
          | 
            
              US20010003580A1
              (en)
            
            
            
           | 
          1998-01-14 | 
          2001-06-14 | 
          Poh K. Hui | 
          Preparation of a lipid blend and a phospholipid suspension containing the lipid blend 
      | 
        
        
          | 
            
              EP1087753A4
              (en)
            
            *
            
           | 
          1998-05-19 | 
          2004-06-30 | 
          Sdg Inc | 
          
  TARGETED LIPOSOMAL DRUG ADMINISTRATION SYSTEM
 
        | 
        
        
          | 
            
              US7169410B1
              (en)
            
            *
            
           | 
          1998-05-19 | 
          2007-01-30 | 
          Sdg, Inc. | 
          Targeted liposomal drug delivery system 
        | 
        
        
          | 
            
              US7871641B2
              (en)
            
            *
            
           | 
          1998-05-19 | 
          2011-01-18 | 
          Sdg, Inc. | 
          Hepatocyte-targeting vehicle for delivery of glargine insulin to a mammal 
        | 
        
        
          | 
            
              US7311924B2
              (en)
            
            
            
           | 
          1999-04-01 | 
          2007-12-25 | 
          Hana Biosciences, Inc. | 
          Compositions and methods for treating cancer 
        | 
        
        
          | 
            
              CA2366787C
              (en)
            
            
            
           | 
          1999-04-01 | 
          2013-03-12 | 
          Inex Pharmaceuticals Corp. | 
          Compositions and methods for treating lymphoma 
      | 
        
        
          | 
            
              US7244450B2
              (en)
            
            *
            
           | 
          1999-04-01 | 
          2007-07-17 | 
          Inex Pharmaceuticals Corporation | 
          Compositions and methods for treating lymphoma 
        | 
        
        
          | 
            
              US6723338B1
              (en)
            
            *
            
           | 
          1999-04-01 | 
          2004-04-20 | 
          Inex Pharmaceuticals Corporation | 
          Compositions and methods for treating lymphoma 
        | 
        
        
          | 
            
              AU5269800A
              (en)
            
            
            
           | 
          1999-05-14 | 
          2000-12-05 | 
          Arbor Vita Corporation | 
          Molecular interactions in allergy cells 
      | 
        
        
          | 
            
              DK1860188T3
              (da)
            
            
            
           | 
          1999-07-07 | 
          2011-06-27 | 
          Zymogenetics Inc | 
          Human cytokin-receptor 
        | 
        
        
          | 
            
              US7449339B2
              (en)
            
            *
            
           | 
          1999-11-23 | 
          2008-11-11 | 
          Nir Diagnostics Inc. | 
          Spectroscopic method and apparatus for total hemoglobin measurement 
        | 
        
        
          | 
            
              US6949384B2
              (en)
            
            *
            
           | 
          2001-12-21 | 
          2005-09-27 | 
          Spectromedical Inc. | 
          Method for monitoring degradation of Hb-based blood substitutes 
        | 
        
        
          | 
            
              US20050037505A1
              (en)
            
            *
            
           | 
          2000-05-11 | 
          2005-02-17 | 
          James Samsoondar | 
          Spectroscopic method and apparatus for analyte measurement 
        | 
        
        
          | 
            
              DE60143192D1
              (de)
            
            
            
           | 
          2000-02-08 | 
          2010-11-18 | 
          Sangamo Biosciences Inc | 
          Zellen zur entdeckung von medikamenten 
        | 
        
        
          | 
            
              DK1436003T3
              (da)
            
            
            
           | 
          2001-05-24 | 
          2010-03-15 | 
          Zymogenetics Inc | 
          TACI-immunoglobulin-fusionsproteiner 
        | 
        
        
          | 
            
              CA2461290C
              (en)
            
            
            
           | 
          2001-09-24 | 
          2014-11-25 | 
          Sangamo Biosciences, Inc. | 
          Modulation of stem cells using zinc finger proteins 
      | 
        
        
          | 
            
              EP2292271A3
              (en)
            
            
            
           | 
          2001-10-10 | 
          2011-09-14 | 
          BioGeneriX AG | 
          Remodelling and glycoconjugation of an antibody 
        | 
        
        
          | 
            
              AU2003280410B8
              (en)
            
            
            
           | 
          2002-01-18 | 
          2009-04-23 | 
          Zymogenetics, Inc. | 
          Cytokine receptor zcytor17 multimers 
        | 
        
        
          | 
            
              JP4795641B2
              (ja)
            
            
            
           | 
          2002-01-18 | 
          2011-10-19 | 
          ザイモジェネティクス,  インコーポレイテッド | 
          新規サイトカインzcytor17リガンド 
        | 
        
        
          | 
            
              CA2480176A1
              (en)
            
            *
            
           | 
          2002-04-11 | 
          2003-10-23 | 
          Zymogenetics, Inc. | 
          Use of interleukin-24 to treat ovarian cancer 
      | 
        
        
          | 
            
              US7273620B1
              (en)
            
            
            
           | 
          2002-05-20 | 
          2007-09-25 | 
          University Of British Columbia | 
          Triggered release of liposomal drugs following mixing of cationic and anionic liposomes 
        | 
        
        
          | 
            
              ES2420581T3
              (es)
            
            
            
           | 
          2003-03-14 | 
          2013-08-26 | 
          Biogenerix Gmbh | 
          Polímeros solubles en agua ramificados y sus conjugados 
        | 
        
        
          | 
            
              EP2338333B1
              (en)
            
            
            
           | 
          2003-04-09 | 
          2017-09-06 | 
          ratiopharm GmbH | 
          Glycopegylation methods and proteins/peptides produced by the methods 
        | 
        
        
          | 
            
              DK2927318T3
              (da)
            
            
            
           | 
          2003-08-08 | 
          2020-08-03 | 
          Sangamo Therapeutics Inc | 
          Fremgangsmåde og sammensætninger til målrettet spaltning og rekombination 
        | 
        
        
          | 
            
              US7888121B2
              (en)
            
            
            
           | 
          2003-08-08 | 
          2011-02-15 | 
          Sangamo Biosciences, Inc. | 
          Methods and compositions for targeted cleavage and recombination 
        | 
        
        
          | 
            
              US7407776B2
              (en)
            
            
            
           | 
          2003-09-19 | 
          2008-08-05 | 
          Sangamo Biosciences, Inc. | 
          Engineered zinc finger proteins for regulation of gene expression 
        | 
        
        
          | 
            
              US20080119412A1
              (en)
            
            
            
           | 
          2003-12-23 | 
          2008-05-22 | 
          Nono Inc. | 
          Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins 
        | 
        
        
          | 
            
              US7534775B2
              (en)
            
            *
            
           | 
          2004-04-08 | 
          2009-05-19 | 
          Sangamo Biosciences, Inc. | 
          Methods and compositions for modulating cardiac contractility 
        | 
        
        
          | 
            
              WO2005099771A2
              (en)
            
            *
            
           | 
          2004-04-08 | 
          2005-10-27 | 
          Sangamo Biosciences, Inc. | 
          Methods and compositions for treating neuropathic and neurodegenerative conditions 
        | 
        
        
          | 
            
              AU2005251691A1
              (en)
            
            *
            
           | 
          2004-05-17 | 
          2005-12-22 | 
          Tekmira Pharmaceuticals Corporation | 
          Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof 
      | 
        
        
          | 
            
              EP1789095A2
              (en)
            
            *
            
           | 
          2004-09-16 | 
          2007-05-30 | 
          Sangamo Biosciences Inc. | 
          Compositions and methods for protein production 
        | 
        
        
          | 
            
              KR100695742B1
              (ko)
            
            
            
           | 
          2004-11-30 | 
          2007-03-19 | 
          한국원자력연구소 | 
          마이크로파 조사를 이용한 disida 및 그 유도체 또는 메브로페닌의 제조 방법 
        | 
        
        
          | 
            
              MX2007008229A
              (es)
            
            
            
           | 
          2005-01-10 | 
          2007-09-11 | 
          Neose Technologies Inc | 
          Factor estimulador de colonias de granulocitos glicopegilado. 
        | 
        
        
          | 
            
              AU2006212807A1
              (en)
            
            
            
           | 
          2005-02-08 | 
          2006-08-17 | 
          Zymogenetics, Inc. | 
          Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation 
      | 
        
        
          | 
            
              CA2599004C
              (en)
            
            
            
           | 
          2005-02-28 | 
          2015-05-26 | 
          Sangamo Biosciences, Inc. | 
          Anti-angiogenic methods and compositions 
      | 
        
        
          | 
            
              US9187546B2
              (en)
            
            
            
           | 
          2005-04-08 | 
          2015-11-17 | 
          Novo Nordisk A/S | 
          Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants 
        | 
        
        
          | 
            
              ES2561628T3
              (es)
            
            
            
           | 
          2005-05-06 | 
          2016-02-29 | 
          Zymogenetics, Inc. | 
          Anticuerpos monoclonales IL-31 y métodos de uso 
        | 
        
        
          | 
            
              WO2006124667A2
              (en)
            
            
            
           | 
          2005-05-12 | 
          2006-11-23 | 
          Zymogenetics, Inc. | 
          Compositions and methods for modulating immune responses 
        | 
        
        
          | 
            
              DE102005023442A1
              (de)
            
            *
            
           | 
          2005-05-20 | 
          2006-11-30 | 
          BSH Bosch und Siemens Hausgeräte GmbH | 
          Haushaltgerät zur Pflege von Wäschestücken insbesondere Wäschetrockner 
        | 
        
        
          | 
            
              EP3391876B1
              (en)
            
            
            
           | 
          2005-05-23 | 
          2021-03-10 | 
          SDG, Inc. | 
          Lipid construct for delivery of insulin to a mammal 
        | 
        
        
          | 
            
              JP2008542270A
              (ja)
            
            *
            
           | 
          2005-05-23 | 
          2008-11-27 | 
          エスデイージー・インコーポレーテツド | 
          インターフェロンを哺乳動物に送達するための脂質構築物 
        | 
        
        
          | 
            
              JP5414270B2
              (ja)
            
            *
            
           | 
          2005-05-23 | 
          2014-02-12 | 
          エスデイージー・インコーポレーテツド | 
          インスリンを哺乳動物に送達するための脂質構築物 
        | 
        
        
          | 
            
              AU2012247063B2
              (en)
            
            *
            
           | 
          2005-05-23 | 
          2015-07-30 | 
          Sdg, Inc. | 
          Lipid construct for delivery of insulin to a mammal 
        | 
        
        
          | 
            
              US20110135725A1
              (en)
            
            *
            
           | 
          2005-05-23 | 
          2011-06-09 | 
          Sdg, Inc. | 
          Lipid Construct for Delivery of Insulin to a Mammal 
        | 
        
        
          | 
            
              US20070218117A1
              (en)
            
            *
            
           | 
          2006-03-20 | 
          2007-09-20 | 
          Sdg, Inc. | 
          Supra molecular construct for delivery of interferon to a mammal 
        | 
        
        
          | 
            
              AU2006272634B2
              (en)
            
            
            
           | 
          2005-07-26 | 
          2013-01-24 | 
          Sangamo Therapeutics, Inc. | 
          Targeted integration and expression of exogenous nucleic acid sequences 
        | 
        
        
          | 
            
              RU2448703C2
              (ru)
            
            
            
           | 
          2005-11-23 | 
          2012-04-27 | 
          Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем | 
          Онкогенное ras-специфичное цитотоксическое соединение и способы его применения 
        | 
        
        
          | 
            
              CA2632215A1
              (en)
            
            
            
           | 
          2005-11-28 | 
          2007-10-04 | 
          Zymogenetics, Inc. | 
          Il-21 monoclonal antibodies 
      | 
        
        
          | 
            
              AU2007226627B2
              (en)
            
            
            
           | 
          2006-03-10 | 
          2012-09-20 | 
          Zymogenetics, Inc. | 
          Antibodies that bind both IL-17A and IL-17F and methods of using the same 
        | 
        
        
          | 
            
              WO2008060780A2
              (en)
            
            
            
           | 
          2006-10-04 | 
          2008-05-22 | 
          Novo Nordisk A/S | 
          Glycerol linked pegylated sugars and glycopeptides 
        | 
        
        
          | 
            
              LT2662091T
              (lt)
            
            
            
           | 
          2006-12-01 | 
          2018-12-10 | 
          Novartis Ag | 
          Anti-p-selektino antikūnai ir jų naudojimo būdai uždegiminių ligų gydymui 
        | 
        
        
          | 
            
              KR100700419B1
              (ko)
            
            
            
           | 
          2006-12-22 | 
          2007-03-28 | 
          한국원자력연구소 | 
          마이크로파 조사를 이용한 disida 및 그 유도체 또는메브로페닌의 제조 방법 
        | 
        
        
          | 
            
              EP2392597B1
              (en)
            
            
            
           | 
          2007-04-27 | 
          2014-04-02 | 
          ZymoGenetics, Inc. | 
          Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use 
        | 
        
        
          | 
            
              US20100080773A1
              (en)
            
            
            
           | 
          2008-09-26 | 
          2010-04-01 | 
          Sdg, Inc. | 
          Orally Bioavailable Lipid-Based Constructs 
        | 
        
        
          | 
            
              US9145453B2
              (en)
            
            *
            
           | 
          2007-09-28 | 
          2015-09-29 | 
          Sdg, Inc. | 
          Orally bioavailable lipid-based constructs 
        | 
        
        
          | 
            
              US8962015B2
              (en)
            
            *
            
           | 
          2007-09-28 | 
          2015-02-24 | 
          Sdg, Inc. | 
          Orally bioavailable lipid-based constructs 
        | 
        
        
          | 
            
              US8846053B2
              (en)
            
            
            
           | 
          2008-09-26 | 
          2014-09-30 | 
          Sdg, Inc. | 
          Orally bioavailable lipid-based constructs 
        | 
        
        
          | 
            
              JP5749494B2
              (ja)
            
            
            
           | 
          2008-01-02 | 
          2015-07-15 | 
          テクミラ ファーマシューティカルズ コーポレイション | 
          核酸の送達のための改善された組成物および方法 
        | 
        
        
          | 
            
              KR101614494B1
              (ko)
            
            
            
           | 
          2008-04-02 | 
          2016-04-22 | 
          마크로제닉스, 인크. | 
          Bcr-복합체-특이적 항체 및 그것의 사용 방법 
        | 
        
        
          | 
            
              SG189730A1
              (en)
            
            
            
           | 
          2008-04-02 | 
          2013-05-31 | 
          Macrogenics Inc | 
          Her2/neu-specific antibodies and methods of using same 
      | 
        
        
          | 
            
              WO2009136965A1
              (en)
            
            *
            
           | 
          2008-05-06 | 
          2009-11-12 | 
          Sequella, Inc. | 
          Compositions and methods comprising capuramycin analogues 
        | 
        
        
          | 
            
              WO2010033279A2
              (en)
            
            
            
           | 
          2008-06-04 | 
          2010-03-25 | 
          Macrogenics, Inc. | 
          Antibodies with altered binding to fcrn and methods of using same 
        | 
        
        
          | 
            
              PL2350043T3
              (pl)
            
            
            
           | 
          2008-10-09 | 
          2014-09-30 | 
          Tekmira Pharmaceuticals Corp | 
          Ulepszone aminolipidy i sposoby dostarczania kwasów nukleinowych 
        | 
        
        
          | 
            
              CN105709229B
              (zh)
            
            
            
           | 
          2008-11-10 | 
          2020-07-28 | 
          阿布特斯生物制药公司 | 
          用于递送治疗剂的新型脂质和组合物 
        | 
        
        
          | 
            
              BRPI1007466A2
              (pt)
            
            
            
           | 
          2009-01-28 | 
          2018-06-12 | 
          Smartcells Inc | 
          conjugado de insulina cristalina, formulação de liberação prolongada, e, sistema de distribuição de bomba 
        | 
        
        
          | 
            
              CA2750262C
              (en)
            
            
            
           | 
          2009-01-28 | 
          2016-08-09 | 
          Smartcells, Inc. | 
          Conjugate based systems for controlled drug delivery 
        | 
        
        
          | 
            
              EP2391216A4
              (en)
            
            
            
           | 
          2009-01-28 | 
          2013-06-19 | 
          Smartcells Inc | 
          
  EXTINGUISHING EXTRACTED SUBSTANCES AND THEIR USE
 
        | 
        
        
          | 
            
              US8940690B2
              (en)
            
            
            
           | 
          2009-01-28 | 
          2015-01-27 | 
          National Institutes Of Health (Nih) | 
          Synthetic conjugates and uses thereof 
        | 
        
        
          | 
            
              AU2010208035B2
              (en)
            
            
            
           | 
          2009-01-29 | 
          2016-06-23 | 
          Arbutus Biopharma Corporation | 
          Improved lipid formulation for the delivery of nucleic acids 
        | 
        
        
          | 
            
              WO2010105209A1
              (en)
            
            
            
           | 
          2009-03-12 | 
          2010-09-16 | 
          Alnylam Pharmaceuticals, Inc. | 
          LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES 
        | 
        
        
          | 
            
              CA2754950A1
              (en)
            
            
            
           | 
          2009-03-20 | 
          2010-09-23 | 
          Smartcells, Inc. | 
          Terminally-functionalized conjugates and uses thereof 
      | 
        
        
          | 
            
              EP2408470A4
              (en)
            
            
            
           | 
          2009-03-20 | 
          2012-08-29 | 
          Smartcells Inc | 
          
  SOLUBLE NONDEPOT INSULIN CONJUGATE AND ITS USE
 
        | 
        
        
          | 
            
              KR20210031549A
              (ko)
            
            
            
           | 
          2009-05-05 | 
          2021-03-19 | 
          알닐람 파마슈티칼스 인코포레이티드 | 
          지질 조성물 
        | 
        
        
          | 
            
              CA2760706C
              (en)
            
            
            
           | 
          2009-05-05 | 
          2019-08-06 | 
          Alnylam Pharmaceuticals, Inc. | 
          Methods of delivering oligonucleotides to immune cells 
        | 
        
        
          | 
            
              KR102374518B1
              (ko)
            
            
            
           | 
          2009-06-10 | 
          2022-03-16 | 
          알닐람 파마슈티칼스 인코포레이티드 | 
          향상된 지질 조성물 
        | 
        
        
          | 
            
              WO2011009624A1
              (en)
            
            
            
           | 
          2009-07-22 | 
          2011-01-27 | 
          Cenix Bioscience Gmbh | 
          Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes 
        | 
        
        
          | 
            
              EP2464336A4
              (en)
            
            
            
           | 
          2009-08-14 | 
          2013-11-20 | 
          Alnylam Pharmaceuticals Inc | 
          
  COMPOSITIONS FORMULATED IN LIPIDS AND METHODS OF INHIBITING THE EXPRESSION OF EBOLA VIRUS GENE
 
        | 
        
        
          | 
            
              EP2497498A4
              (en)
            
            
            
           | 
          2009-11-05 | 
          2013-04-17 | 
          Univ Osaka | 
          
        THERAPEUTIC ACTIVE FOR AUTOIMMUNE DISEASES OR ALLERGIES AND METHOD FOR SCREENING AFTER THE THERAPEUTIC ACTIVE SUBSTANCE
       
        | 
        
        
          | 
            
              AU2010328336B2
              (en)
            
            
            
           | 
          2009-12-07 | 
          2017-03-02 | 
          Arbutus Biopharma Corporation | 
          Compositions for nucleic acid delivery 
        | 
        
        
          | 
            
              AU2010330814B2
              (en)
            
            
            
           | 
          2009-12-18 | 
          2017-01-12 | 
          Acuitas Therapeutics Inc. | 
          Methods and compositions for delivery of nucleic acids 
        | 
        
        
          | 
            
              WO2011085990A1
              (en)
            
            
            
           | 
          2010-01-13 | 
          2011-07-21 | 
          Institut Pasteur Korea | 
          Anti - infective pyrido (1,2 -a) pyrimidines 
        | 
        
        
          | 
            
              WO2011116396A2
              (en)
            
            
            
           | 
          2010-03-19 | 
          2011-09-22 | 
          The Board Of Trustees Of The Leland Stanford Junior University | 
          Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists 
        | 
        
        
          | 
            
              WO2011139911A2
              (en)
            
            
            
           | 
          2010-04-29 | 
          2011-11-10 | 
          Isis Pharmaceuticals, Inc. | 
          Lipid formulated single stranded rna 
        | 
        
        
          | 
            
              KR101967411B1
              (ko)
            
            
            
           | 
          2010-06-03 | 
          2019-04-10 | 
          알닐람 파마슈티칼스 인코포레이티드 | 
          활성제의 전달을 위한 생분해성 지질 
        | 
        
        
          | 
            
              AU2011282988A1
              (en)
            
            
            
           | 
          2010-07-28 | 
          2013-01-31 | 
          Smartcells, Inc. | 
          Recombinantly expressed insulin polypeptides and uses thereof 
      | 
        
        
          | 
            
              CA2805739A1
              (en)
            
            
            
           | 
          2010-07-28 | 
          2012-02-02 | 
          Smartcells, Inc. | 
          Drug-ligand conjugates, synthesis thereof, and intermediates thereto 
      | 
        
        
          | 
            
              EP2598522A4
              (en)
            
            
            
           | 
          2010-07-28 | 
          2014-11-12 | 
          Smartcells Inc | 
          
  RECOMBINANT LECTINES, LECTINES WITH MODIFIED BINDING SITE AND USES THEREOF
 
        | 
        
        
          | 
            
              US20130202652A1
              (en)
            
            
            
           | 
          2010-07-30 | 
          2013-08-08 | 
          Alnylam Pharmaceuticals, Inc. | 
          Methods and compositions for delivery of active agents 
        | 
        
        
          | 
            
              US20130323269A1
              (en)
            
            
            
           | 
          2010-07-30 | 
          2013-12-05 | 
          Muthiah Manoharan | 
          Methods and compositions for delivery of active agents 
      | 
        
        
          | 
            
              EP2633316A1
              (en)
            
            
            
           | 
          2010-10-28 | 
          2013-09-04 | 
          Jonas Nilsson | 
          Diagnosis and treatment of alzheimer's disease 
        | 
        
        
          | 
            
              US9339513B2
              (en)
            
            
            
           | 
          2010-11-09 | 
          2016-05-17 | 
          Alnylam Pharmaceuticals, Inc. | 
          Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes 
        | 
        
        
          | 
            
              US9211346B2
              (en)
            
            
            
           | 
          2010-12-13 | 
          2015-12-15 | 
          Trustees Of Dartmouth College | 
          Carrier-linked magnetic nanoparticle drug delivery composition and method of use 
        | 
        
        
          | 
            
              DK2663548T3
              (en)
            
            
            
           | 
          2011-01-11 | 
          2017-07-24 | 
          Alnylam Pharmaceuticals Inc | 
          
  PEGYLED LIPIDS AND THEIR USE FOR PHARMACEUTICAL SUPPLY
 
      | 
        
        
          | 
            
              US20140274812A1
              (en)
            
            
            
           | 
          2011-07-15 | 
          2014-09-18 | 
          The General Hospital Corporation | 
          Methods of Transcription Activator Like Effector Assembly 
        | 
        
        
          | 
            
              AU2012315965A1
              (en)
            
            
            
           | 
          2011-09-27 | 
          2014-04-03 | 
          Alnylam Pharmaceuticals, Inc. | 
          Di-aliphatic substituted PEGylated lipids 
      | 
        
        
          | 
            
              US9708401B2
              (en)
            
            
            
           | 
          2012-05-22 | 
          2017-07-18 | 
          Bristol-Myers Squibb Company | 
          IL-17A/F cross-reactive monoclonal antibodies and methods of using the same 
        | 
        
        
          | 
            
              US9890364B2
              (en)
            
            
            
           | 
          2012-05-29 | 
          2018-02-13 | 
          The General Hospital Corporation | 
          TAL-Tet1 fusion proteins and methods of use thereof 
        | 
        
        
          | 
            
              EP3789405A1
              (en)
            
            
            
           | 
          2012-10-12 | 
          2021-03-10 | 
          The General Hospital Corporation | 
          Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins 
        | 
        
        
          | 
            
              US9801874B2
              (en)
            
            
            
           | 
          2012-11-20 | 
          2017-10-31 | 
          Spectrum Pharmaceuticals | 
          Method for the preparation of liposome encapsulated vincristine for therapeutic use 
        | 
        
        
          | 
            
              CA2900338A1
              (en)
            
            
            
           | 
          2013-02-07 | 
          2014-08-14 | 
          The General Hospital Corporation | 
          Tale transcriptional activators 
      | 
        
        
          | 
            
              US10760064B2
              (en)
            
            
            
           | 
          2013-03-15 | 
          2020-09-01 | 
          The General Hospital Corporation | 
          RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci 
        | 
        
        
          | 
            
              WO2014204578A1
              (en)
            
            
            
           | 
          2013-06-21 | 
          2014-12-24 | 
          The General Hospital Corporation | 
          Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing 
        | 
        
        
          | 
            
              CN113563476A
              (zh)
            
            
            
           | 
          2013-03-15 | 
          2021-10-29 | 
          通用医疗公司 | 
          遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向 
        | 
        
        
          | 
            
              US9427475B2
              (en)
            
            
            
           | 
          2013-10-04 | 
          2016-08-30 | 
          Merck Sharp & Dohme Corp. | 
          Glucose-responsive insulin conjugates 
        | 
        
        
          | 
            
              HK1243021A1
              (zh)
            
            
            
           | 
          2014-10-14 | 
          2018-07-06 | 
          The Regents Of The University Of California | 
          使用cdk9和brd4抑制剂来抑制炎症 
      | 
        
        
          | 
            
              WO2016118697A1
              (en)
            
            
            
           | 
          2015-01-21 | 
          2016-07-28 | 
          Phaserx, Inc. | 
          Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells 
        | 
        
        
          | 
            
              EP3294887A1
              (en)
            
            
            
           | 
          2015-05-14 | 
          2018-03-21 | 
          CNIC Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | 
          Mirna compositions for the treatment of mature b-cell neoplasms 
        | 
        
        
          | 
            
              TWI678213B
              (zh)
            
            
            
           | 
          2015-07-22 | 
          2019-12-01 | 
          美商史倍壯製藥公司 | 
          用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物 
        | 
        
        
          | 
            
              US9926546B2
              (en)
            
            
            
           | 
          2015-08-28 | 
          2018-03-27 | 
          The General Hospital Corporation | 
          Engineered CRISPR-Cas9 nucleases 
        | 
        
        
          | 
            
              US9512446B1
              (en)
            
            
            
           | 
          2015-08-28 | 
          2016-12-06 | 
          The General Hospital Corporation | 
          Engineered CRISPR-Cas9 nucleases 
        | 
        
        
          | 
            
              CR20180365A
              (es)
            
            
            
           | 
          2015-12-16 | 
          2018-09-28 | 
          Amgen Inc | 
          PROTEÍNAS DE UNIÓN AL ANTÍGENO BISPECÍFICO DE ANTI-TL1A/ANTI-TNF-a Y SUS USOS 
        | 
        
        
          | 
            
              US10519442B2
              (en)
            
            
            
           | 
          2016-02-11 | 
          2019-12-31 | 
          City Of Hope | 
          Twist signaling inhibitor compositions and methods of using the same 
        | 
        
        
          | 
            
              US11779657B2
              (en)
            
            
            
           | 
          2016-06-10 | 
          2023-10-10 | 
          City Of Hope | 
          Compositions and methods for mitochondrial genome editing 
        | 
        
        
          | 
            
              US10646540B2
              (en)
            
            
            
           | 
          2016-11-18 | 
          2020-05-12 | 
          City Of Hope | 
          Peptide inhibitors of twist 
        | 
        
        
          | 
            
              CA3055561A1
              (en)
            
            
            
           | 
          2017-03-13 | 
          2018-09-20 | 
          Sdg, Inc. | 
          Lipid-based nanoparticles with enhanced stability 
        | 
        
        
          | 
            
              US11077173B2
              (en)
            
            
            
           | 
          2017-03-13 | 
          2021-08-03 | 
          Sdg, Inc. | 
          Lipid-based nanoparticles and methods using same 
        | 
        
        
          | 
            
              WO2019086626A1
              (en)
            
            
            
           | 
          2017-11-03 | 
          2019-05-09 | 
          Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.) | 
          MIRNAs AND COMBINATIONS THEREOF FOR USE IN THE TREATMENT OF HUMAN B CELL NEOPLASIAS 
        | 
        
        
          | 
            
              KR20200106912A
              (ko)
            
            *
            
           | 
          2018-01-05 | 
          2020-09-15 | 
          에스디지,인코포레이티드 | 
          당뇨병을 치료하기 위한 지질 기반 나노입자를 포함하는 조성물 
        |